Wells Fargo & Company Maravai Lifesciences Holdings, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 39,470 shares of MRVI stock, worth $309,444. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,470
Previous 8,294
375.89%
Holding current value
$309,444
Previous $71,000
297.18%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MRVI
# of Institutions
224Shares Held
125MCall Options Held
176KPut Options Held
2.2K-
12 West Capital Management LP New York, NY13.2MShares$104 Million9.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$84.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$76.3 Million0.0% of portfolio
-
Braidwell LP Stamford, CT9.02MShares$70.7 Million2.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$46.8 Million0.02% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $1.03B
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...